MedTrace Logo

Efficacy of Intravenous In-line Filter in Patient Undergoing Cardiac Surgery

NCT03784521 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 486

Last updated 2024-03-15

No results posted yet for this study

Summary

The aim of this study is to demonstrated efficacy of in-line filtration to reduce systemic inflammatory response syndrome (SIRS) ,specific organ dysfunction and complications in adult cardiac surgery. 486 patients undergoing cardiac surgery for acquired heart disease are 1:1 randomized into in-line filtration (study group) and non-filtration (control group). The incidence of SIRS, complications, daily SOFA (sequential organ failure assessment) score are compared between groups.

Conditions

  • SIRS

Interventions

DEVICE

In-line filtration

In-line filtration is used during anesthesia and intensive care unit in study group to purify fluids administrations.

DEVICE

Standard care

Patients are treated with standard intravenous solutions and vascular access management

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Principal Investigators

  • Narongrit Kantathut, MD · Ramathibodi hospital, Mahidol University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-03
Primary Completion
2023-06-30
Completion
2023-06-30

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03784521 on ClinicalTrials.gov